There is a need for biomarkers for amyotrophic lateral sclerosis (ALS), to support the diagnosis of the disease, to predict disease progression and to track disease activity and treatment responses. Over the last decade multiple studies have investigated the potential of neurofilament levels, both i...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!